Blueberries Medical Corp BBRRF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.01
- Day Range
- $0.01–0.01
- 52-Week Range
- $0.01–0.03
- Bid/Ask
- $0.01 / $0.02
- Market Cap
- $5.35 Mil
- Volume/Avg
- 40,000 / 48,372
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 15.97
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Blueberries Medical Corp is a licensed producer of psychoactive and non-psychoactive cannabis by-products in Colombia. It cultivates, produces, and distributes cannabidiol (CBD) and THC (tetrahydrocannabinol) based medical cannabis domestically as well as internationally. The company generates all of its revenues from Colombia.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- —
- Website
- https://www.blueberriesmed.com
Valuation
|
Metric
|
BBRRF
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 4.09 |
Price/Sales | 15.97 |
Price/Cash Flow | — |
Price/Earnings
BBRRF
Financial Strength
|
Metric
|
BBRRF
|
|---|---|
Quick Ratio | 1.81 |
Current Ratio | 3.41 |
Interest Coverage | −8.43 |
Quick Ratio
BBRRF
Profitability
|
Metric
|
BBRRF
|
|---|---|
Return on Assets (Normalized) | −44.17% |
Return on Equity (Normalized) | −98.34% |
Return on Invested Capital (Normalized) | −48.27% |
Return on Assets
BBRRF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| Djrrdmpyd | Djnnwvw | $80.3 Bil | |||
| Zoetis Inc Class A
ZTS
| Qrddbdkx | Hftr | $77.8 Bil | |||
| Haleon PLC ADR
HLN
| Fhqlpsn | Jfjm | $37.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Tkpqtkpg | Tsqx | $12.1 Bil | |||
| Viatris Inc
VTRS
| Kllnbyh | Gzsf | $12.1 Bil | |||
| Catalent Inc
CTLT
| Fkvsdmclh | Lcctmgq | $10.0 Bil | |||
| Perrigo Co PLC
PRGO
| Hgzdrfdm | Vchl | $3.7 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Htlbbfzm | Pmvszq | $3.2 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Gkgwbmyy | Xbdd | $3.0 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Znzpzprv | Slq | $2.7 Bil |